SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-002130
Filing Date
2023-11-13
Accepted
2023-11-13 06:38:20
Documents
50
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20230930.htm   iXBRL 10-Q 486306
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 7914
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4319
  Complete submission text file 0001096906-23-002130.txt   2466024

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20230930_cal.xml EX-101.CAL 17991
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20230930_def.xml EX-101.DEF 58481
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20230930_lab.xml EX-101.LAB 152020
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20230930_pre.xml EX-101.PRE 128940
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20230930.xsd EX-101.SCH 29114
44 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20230930_htm.xml XML 275531
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

IRS No.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 231394925
SIC: 2833 Medicinal Chemicals & Botanical Products